Vimarsana
Biggest News Aggregation in the World

Humant Activator News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Humant Activator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Humant Activator Today - Breaking & Trending Today

Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: An explanatory study in Japan - Vimarsana News

Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: An explanatory study in Japan

Glucocorticoids, TNFis, and abatacept treatments negatively affect the longevity of humoral responses to SARS-CoV-2, including Omicron, after two vaccine doses. These findings may inform the timing of additional vaccination for AIRD patients.

Bispecific antibodies targeting mutant RAS neoantigens - Vimarsana News

Bispecific antibodies targeting mutant RAS neoantigens

Diabodies see the unseeable RAS oncogene mutations are common in various cancers, controlling their growth and survival. Targeting mutant RAS proteins with antibodies has been unsuccessful due to low surface expression, even when targeting mutant RAS peptides presented via HLA on the surface of cancer cells. Douglass et al. used phage display to generate single-chain variable fragments (scFvs) specific for mutant RAS peptide-HLA complexes. The authors tested various bispecific, T cell–engaging antibody formulations, finding that single-chain diabodies (scDbs) combining the aforementioned s...